AMPA receptor potentiators: Application for depression and Parkinson's disease

Current Drug Targets

Volumn 8, Issue 5, 2007, Pages 603-620

  O'Neill, Michael J ^a   Witkin, Jeffrey M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

AMPA receptor potentiator; BDNF; Depression; Glutamate; LY392098; LY404187; LY503430; Parkinson's disease

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 PYRROLIDONE DERIVATIVE; 2,3 DIHYDRO 3,4 CYCLOPENTANO 1,2,4 BENZOTHIADIAZINE 1,1 DIOXIDE; 6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; 7 CHLORO 3,4 DIHYDRO 3 METHYL 2H 1,2,4 BENZOTHIADIAZINE 1,1 DIOXIDE; AMPA RECEPTOR AGONIST; ANIRACETAM; BENZOTHIADIAZINE DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; CX 546; CYCLOTHIAZIDE; DESIPRAMINE; DIAZOXIDE; FLUOXETINE; IMIPRAMINE; LEVODOPA; LY 392098; LY 404187; LY 450108; LY 451395; LY 503430; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER RECEPTOR; NIMODIPINE; PIPERIDINE DERIVATIVE; PIRACETAM; SULFONAMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; DEPRESSION; DOWNSTREAM PROCESSING; DRUG BINDING SITE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; MAMMAL; MEMORY; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; SYNAPTIC TRANSMISSION;

ANIMALS; DEPRESSIVE DISORDER; DRUG SYNERGISM; EXCITATORY AMINO ACID AGONISTS; HUMANS; PARKINSON DISEASE; RECEPTORS, AMPA; SULFONAMIDES; THIOPHENES;

EID: 34249098796     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945007780618517     Document Type: Review

References (177)

1. O'Neill, M.J.; Bleakman, D.; Zimmermann D.M. and Nisenbaum, E.S. (2004) Curr. Drug Targets CNS Neurol. Disord., 3, 181-194.
2. Miu, P.; Jarvie, K.; Radhakrishnan, V.; Gates, M.; Ogden, A.; Ornstein, P.; Zarrinmayeh, H.; Ho, K.; Peters, D.; Grabell, J.; Gupta, A.; Zimmerman, D. and Bleakman, D. (2001) Neuropharmacology, 40, 976-983.
3. Murray, T.K.; Whalley, K.; Robinson, C.; Ward, M.A.; Hicks, C.A.; Lodge, D.; Vandergriff, J.; Baumbarger, P.; Suida, E.; Gates, M.; Ogden, A.M.; Skolnick, P.; Zimmerman, D.M.; Nisenbaum, E.S.; Bleakman, D. and O'Neill, M.J. (2003) J. Pharmacol. Exp. Ther., 306, 752-762.
4. O'Neill, M.J.; Murray, T.K.; Clay, M.P.; Lindstrom, T.; Yang, C.R. and Nisenbaum, E.S. (2005) CNS Drug Rev., 11, 77-96.
5. Gates, M., Ogden, A. and Bleakman, D. (2001) Neuropharmacology, 40, 984-991.
6. Quirk, J. and Nisenbaum, E. (2002) CNS Drug Rev., 8, 255-282.
7. Baumbarger, P.J.; Muhlhauser, M.; Zhai, J.; Yang, C.R. and Nisenbaum, E.S. (2001) J. Pharmacol. Exp. Ther., 298, 86-102.
8. Vandergriff, J.; Huff, K.; Bond, A. and Lodge, D. (2001) Neuropharmacology 40, 1003-1009.
9. Xia, Y-F., Kessler, M. and Arai, A.C. (2005) J. Pharmacol. Exp. Ther., 213, 277-285.
10. Bliss, T.V. and Lomo, T. (1973) J. Physiol., 232, 331-356.
11. Bliss, T.V. and Collingridge, G.L. (1993) Nature, 361, 31-39.
12. Lynch, G. and Baudry, M. (1984) Science, 224, 1057-1063.
13. Malenka, R.C. and Nicoll, R.A. (1999) Science, 285, 1870-1874.
14. Mayer, M.L. and Westbrook, G.L. (1984) Nature, 309, 261-263.
15. Yamada, K.A. (1998) Neurobiol. Dis., 5, 67-80.
16. Ito, I.; Tanabe, S.; Kohda, A. and Sugiyama, H. (1990) J. Phsyiol., 424, 533-543.
17. Arai, A. and Lynch, G. (1998) Brain Res., 799, 230-234.
18. Yamada, K. and Rothman, S.M. (1992) J. Physiol., 458, 385-407.
19. Baumbarger, P.J.; Muhlhauser, M.; Yang, C.R. and Nisenbaum, E.S. (2001) Neuropharmacology, 40, 992-1002.
20. Lynch, G. (2004) Curr. Opin. Pharmacol., 4, 4-11.
21. Pontecorvo, M.J. and Evans, H.L. (1985) Pharmacol. Biochem. Behav., 22, 745-752.
22. Verloes, R.; Scotto, A.M.; Gobert, J. and Wulfert, E. (1988) Psychopharmacology, (Berl) 95, 226-230.
23. Copani, A.; Genazzani, A.; Aleppo, G.; Casabona, G.; Canonico, L.; Scapagnini, U. and Nicoletti, F. (1992) J. Neurochem., 58, 1199-1204.
24. Staubli, U.; Rogers, G. and Lynch, G. (1994) Proc. Natl. Acad. Sci. USA, 91, 777-781.
25. Staubli, U.; Perez, Y.; Xu, F.; Rogers, G.; Ingvar, M.; Stone-Elander, S. and Lynch G. (1994) Proc. Natl. Acad. Sci. USA, 91, 11158-11162.
26. Davies, C.M.; Moskovitz, B.; Nguyen, M.A.; Tran, B.B.; Arai, A.; Lynch, G. and Granger, R. (1997) Psychopharmacology, (Berl), 133, 161-167.
27. Granger, R.; Staubli, U.; Davis, M.; Perez, Y.; Nilsson, L.; Rogers, G.A. and Lynch G. (1993) Synapse, 15, 326-329.
28. Granger, R.;, Deadwyler, S.; Davis, M.; Moskovitz, B.; Kessler, M.; Rogers, G. and Lynch, G. (1996) Synapse, 22, 332-337.
29. Hampson, R.E.; Rogers, G.; Lynch, G. and Deadwyler, S.A. (1998) J. Neurosci., 18, 2740-2747.
30. Zivkovic, I.; Thompson, D.M.; Bertolino, M.; Uzunov, D.; DiBella, M.; Costa, E. and Guidotti, A. (1995) J. Pharmacol. Exp. Ther., 272, 300-309.
31. Thompson, D.M.; Guidotti, A.; DiBella, M. and Costa, E. (1995) Proc. Natl. Acad. Sci. USA, 92, 7667-7671.
32. Hayashi, T.; Umemori, H.; Mishina, M. and Yamamoto, T. (1999) Nature, 397, 72-76.
33. Zafra, F.; Hengerer, B.; Leibrock, J.; Thoenen, H.; Lindholm, D. (1990) EMBO J., 9, 3545-3550.
34. Hardingham, G.E.; Cruzalegui, F.H., Chawla, S. and Bading, H. (1998) Cell Calcium, 23, 131-134.
35. Tao, X; Finkbeiner, S. Arnold, D.B.; Shaywitz, A.J.and Greenberg M.E. (1998) Neuron, 20, 709-726.
36. Zafra, F.; Lindholm, D.; Castren, E.; Hartikka, J. and Thoenen H. (1992) J. Neurosci., 12, 4793-4799.
37. Fowler, J.H.; Whalley, K.; Murray, T.; O'Neill, M.J. and McCulloch, J. (2004) J. Cerebral Blood Flow Metabol., 24(10), 1098-1109.
38. Jones, N., O'Neill, M.J.; Tricklebank, M.D. and Williams, S.C.R. (2005) Psychopharmacology, 180(4), 743-51.
39. Legutko, B.; Li, X. and Skolnick, P. (2001) Neurapharmacology, 40, 1019-1027.
40. Schenk, U.; Menna, E.; Kim, T.; Passafaro, M.; Chang, S.; De Camilli, P. and Matteoli, M. (2005) J. Neurosci., 25(7), 1654-1663.
41. Bai, F.; Bergeron, M. and Nelson, D.L. (2003) Neuropharmacology, 44, 1013-1021.
42. Lauterbom, J.C.; Lynch, G.; Vanderklish, P.; Arai, A. and Gall, C.M. (2000) J. Neurosci., 20, 8-21.
43. Mackowiak, M.; O'Neill, M.J.; Hicks, C.A.; Bleakman, D.; Skolnick, P. (2002) Neuropharmacology, 43, 1-10.
44. Bymaster, F.P.; McNamara, R.K. and Tran, P.V. (2003) Exp. Opin. Invest. Drugs, 12, 531-543.
45. O'Donnell, J.M. and Zhang, Han-Ting. (2004) Trends Pharmacol. Sci., 25(3), 158-163.
46. Tzavara, E.T.; Wade, M. and Nomikos, G.G. (2003) J. Neurosci., 23(28), 9374-9384.
47. Griebel, G.; Stemmelin, J. and Scatton, B. (2005) Biol. Psychiat., 2005,57, 261-267.
48. Katz, M.M.; Tekell, J.L.; Bowden, C.L.; Brannan, S.; Houston, J.P.; Berman, N. and Frazer, A. (2004) Neuropsychopharmacology, 29(3), 566-579.
49. Binder, D.K. and Scharfman, H.E. (2004) Growth Factors, 22(3), 123-131.
50. Altar, C.A.; Boylan, C.B.; Jackson, C.; Hershenson, S.; Miller, J.; Wiegand, S.J.; Lindsay, R.M. and Hyman, C. (1992) Proc. Natl. Acad. Sci. U.S.A., 89, 11347-11351.
51. Lapchak, P.A.; Beck, K.D.; Araujo, D.M.; Irwin, I.; Langston, J.W. and Hefti, F. (1993) Neuroscience, 53, 639-650.
52. Sauer, H.; Fischer, W.; Nikkhah, G.; Wiegand, S.J.; Brundin, P.; Lindsay, R.M. and Bjorklund, A. (1993) Brain Res., 626, 37-44.
53. Siuciak, J.; Altar, C.; Wiegand, S. and Lindsay, R. (1994) Brain Res., 633, 326-330.
54. Siuciak, J.A.; Boylan, C.; Fritsche, M.; Altar, C.A. and Lindsay, R.M. (1996) Brain Res., 710, 11-20.
55. Vaidya, V.A.; Siuciak, J.A.; Du, F. and Duman, R.S. (1999) Neuroscience, 89, 157-66.
56. Duman, R.; Malberg, J. and Nakagawa, S. (2001) J. Pharmacol. Exp. Ther., 299, 401-407.
57. Gorski JA, Zeiler SR, Tamowski S, and Jones KR. (2003) J. Neurosci., 23, 6856-6865.
58. Mamounas, L.; Blue, M.; Siuciak, J. and Altar, C. (1996) J. Neurosci., 15, 7929-7939.
59. Burkhalter, J.; Fiumelli, H.; Allaman, I.; Chatton, J-Y. and Martin, J-L. (2003) J. Neurosci., 23, 8212-8220.
60. Duman, R.S.; Heninger, G.R. and Nestler, E.J. (1997) Arch. General Psychiatry, 54, 597-606.
61. Alt, A.; Witkin, J.M. and Bleakman, D. (2005) Curr. Pharm. Des., (in press).
62. O'Neill, M.J. and Carney, S.L. (2002) Curr. Topics Neurochem., 3, 141-154.
63. Saarelainen, T.; Hendolin, P.; Lucas, G.; Koponen, E.; Sairanen, M.; MacDonald, E.; Agerman, K.; Haapasalo, A.; Nawa, H.; Aloyz, R.; Emfors, P. and Castren, E. (2003) J. Neurosci., 23(1), 349-357.
64. Siuciak, J.; Lewis, D.; Wiegand, S.; Lindsay, R. (1997) Pharmacol. Biochem., Behav. 56, 131-137.
65. Shirayama, Y.; Chen, A.C.; Nakagawa, S.; Russell, D.S. and Duman, R.S. (2002) J. Neurosci., 22, 3251-61.
66. Nibuya, M.; Morinobu, S. and Duman, R. (1995) J. Neurosci., 15, 7539-7547.
67. Brandoli, C.; Sanna, A.; De Bernardi, M.A.; Follesa, P.; Brooker, G. and Mocchetti, I. J. Neurosci., 1998, 18, 7953-61.
68. Smith, M., Makino, S., Altemus, M., Michelson, D., Hong, S.-K., Kvetnansky, R., and Post, R. Proc. Natl. Acad. Sci. USA, 1995, 92, 8788-8792.
69. Russo-Neustadt, A.; Ha, T.; Ramirez, R. and Kesslak, J.P. Behav. Brain Res., 2001, 120, 87-95.
70. Duman, R.S. Biol. Psychiatry, 1998, 44, 324-335.
71. Duman, R.S.; Malberg, J. and Thome, J. Biol. Psychiatry 1999, 46, 1181-1191.
72. Sheline, Y.I.; Wang, P.W.; Gado, M.H.; Csernansky, J.G. and Vannier, M.W. Proc. Natl. Acad. Sci. USA, 1996, 93, 3908-3913.
73. Altieri, M.; Marini. F.; Arban, R.; Vitulli, G. and Jansson, B.O. (2004) Brain Res. 1000(1-2): 148-155.
74. de Foubert, G.; Carney, S.L.; Robinson, C.S.; Destexhe, E.J.; Tomlinson, R.; Hicks, C.A.; Murray, T.K.; Gaillard, J.P.; Deville, C.; Xhenseval, V.; Thomas, C.E.; O'Neill, M.J. and Zederstroem, T.S.C. (2004) Neuroscience, 128(3), 597-604.
75. Conti A.C., Cryan, J.F., Dalvi, A., Lucki, I. and Blendy, J.A. (2002) J. Neurosci., 22, 3262-3268.
76. Altar, C. A.; Whitehead, R. E.; Chen, R.; Woertwein, G. and Madsen, T. M. (2003) Biol. Psychiatry, 54(7), 703-709.
77. Pluijms, E.M.; Birkenhager, T.K.; Huijbrechts, I.P.A.M. and Moleman, P. (2002) J. Affect. Disord, 69(1-3), 93-99.
78. Dias, B.G.; Banerjee, S.B.; Duman, R.S. and Vaidya, V.A. (2003) Neuropharmacology, 45(4), 553-563.
79. Santarelli, L.; Saxe, M.; Gross, C.; Surget, A.; Battaglia, F.; Dulawa, S.; Weisstaub, N.; Lee, J.; Duman, R.; Arancio, O.; Belzung, C. and Hen, R. (2003) Science, 301(5634), 805-809.
80. Mercier, G.; Lennon, A.M.; Renouf, B.; Dessouroux, A.; Ramauge, M.; Courtin, F. and Pierre, M. (2004) J. Mol. Neurosci., 24(2), 207-216.
81. Haynes, L.E.; Barber, D. and Mitchell, L.J. (2004) Brain Res., 1026(2), 157-167.
82. Paul, I.A. and Skolnick, P.(2003) Ann. N.Y. Acad. Sci., 1003, 250-272.
83. Berman R.M.; Cappiello, A.; Anand, A.; Oren, D.A.; Heninger, G.R.; Charney, D.S. and Krystal, J.H. (2000) Biol. Psychiatry, 47(4), 351-354.
84. Kudoh, A.; Takahira, Y.; Katagai, H. and Takazawa, T. (2002) Anesthesia Analgesia, 95(1), 114-118.
85. Sanacora, G.; Gueorguieva, R.; Epperson, C.N.; Wu, Y.T. Appel, M.; Rothman, D.L.; Krystal, J.H. and Mason, G.F. (2004) Archives Gene. Psychiatry, 61(7), 705-713.
86. Li, X.; Tizzano, J.P.; Griffey, K.; Clay, M.; Lindstrom, T. and Skolnick, P. (2001) Neuropharmacology, 40, 1028-1033.
87. Lucki, I. (1997) Behav. Pharmacol., 8(6-7):523-532.
88. O'Neill, M.F. and Moore, N.A. (2003) Hum. Psychopharmacol., 18(4):239-254.
89. Knapp, R.J.; Goldenberg, R.; Shuck, C.; Cecil, A.: Watkins, J.; Miller, C.; Crites, G. and Malatynska, E. (2002) Eur. J. Pharmacol., 440(1), 27-35.
90. Skolnick, P.; Legutko, B.; Li, X. and Bymaster, F.P. (2001) Pharmacol. Res., 43(5), 411-422.
91. Li, X.; Witkin, J.M.; Nead, A.B. and Skolnick, P. (2003) Cell Mol. Neurobiol., 23, 419-430.
92. Meador-Woodruff, J.H.; Hogg, A.J. and Smith, R.E. (2001) Brain Res. Bull., 55, 631-640.
93. Martinez-Turrillas, R.; Frechilla, D. and Del Rio, J. (2002) Neuropharmacology, 43(8):1230-1237.
94. Yan, Z.; Feng, J.; Fienberg, A.A. and Greengard, P. (1999) Proc. Natl. Acad Sci. USA, 96(20): 11607-12.
95. Snyder, G.L.; Allen, P.B.; Fienberg, A.A.; Valle, C.G.; Huganir, R.L.; Nairn, A.C. and Greengard, P. (2000) J. Neurosci., 15; 20(12): 4480-8.
96. Svenningsson, P.; Tzavara, E.T.; Witkin, J.M.; Fienberg, A.A.; Nomikos, G.G. and Greengard, P. (2002) Proc. Natl. Acad. Sci. USA, 99, 3182-3187.
97. Lee, H.K.; Barbarosie, M.; Kameyama, K.; Bear, M.F. and Huganir, R.L. (2000) Nature, 405(6789): 955-9.
98. Ivkovic, S. and Ehrlich, M.E. (1999) J. Neurosci., 19(13), 5409-19.
99. Svenningsson, P.; Tzavara, E.T.; Liu, F.; Fienberg, A.A.; Nomikos, G.G. and Greengard, P. (2002) Proc. Natl. Acad. Sci. USA, 99(5), 3188-3193.
100. Georgescu, D.; Sears, R.M.; Hommel, J.D.; Barrot, M.; Bolanos, C.A.; Marsh, D.J.; Bednarek, M.A.; Bibb, J.A.; Maratos-Flier, E.; Nestler E.J. and DiLeone R.J. (2005) J. Neurosci., 25, 2933-2940.
101. McNaught, K.S.P.; Olanow, C.A.; Halliwell, B.; Isacson, O. and Jenner, P. (2001) Nat. Rev. Neurosci., 2, 589-594.
102. O'Neill, M.J. and Siemers, E.R. (2002) Expert Rev. Neurotherapeut., 2, 89-104.
103. Schapira, A.H.V. and Olanow, C.W. (2004) JAMA, 291, 358-364.
104. Vila, M. and Przedborski, S. (2004) Nat. Med., 10(Suppl), S58-62.
105. Cotzias, G.C.; Papavasiliou, P.S. and Gellene, R. (1969) N. Engl. J. Med., 280, 337-345.
106. Factor, S.A. (1999) Med. Clin. N. Amer., 83, 415-443.
107. Montastruc, J.L.; Rascol, O. and Senard, J.M. (1993) Drugs, 46(3), 384-93.
108. Olanow, C.W.; Watts, R.L. and Koller, W.C. (2001) Neurology, 56(Suppl 5), S1-S88.
109. Pezzoli, G.; Martignoni, E.; Pacchetti, C.; Angeleri, V.A.; Lamberti, P.; Muratorio, A.; Bonuccelli, U.; De Mari, M.; Foschi, N.; Cossutta, E.; Nicoletti, F.; Giammona, F.; Canesi, M.; Scarlato, G.; Caraceni, T.; Moscarelli, E. (1994) Mov. Disord., 9, 431-436.
110. Boas, J., Worm-Petersen, J., Dupont, E., Mikkelsen, B. and Wermuth, L. (1996) Eur. J. Neurol., 3, 44-49.
111. Goetz, C.G. and Diederich, N.J. (1992) Neurologic Clin., 10(2), 527-40.
112. Tulloch, I.F. (1997) Neurology, 49(Suppl 1), S58-S62.
113. Shannon, K.M.; Bennett, J.P. and Friedman, J.H. (1997) Neurology, 49, 724-728.
114. Parkinson Study Group (2000) JAMA, 284, 1931-1938.
115. Rascol, O.; Brooks, D.J.; Korczyn, A.D.; De Deyn, P.P.; Clarke, C.E. and Lang, A.E. for the 056 Study Group (2002) N. Engl. J. Med., 342, 1484-1491.
116. Oertel, W.H.; Wolters, E.; Sampaio, C.; Gimenez-Roldan, S.; Bergamasco, B.; Dujardin, M.; Grosset, D.G.; Arnold, G.; Leenders, K.L.; Hundemer, H-P.; Lledó, A.; Wood, A.; Frewer, P.; Schwarz, J. (2006) Mov. Disord., 21, 343-353.
117. Marek, K.; Seibyl, J.; Shoulson, I.; Holloway, R.; Kieburtz, K.; McDermott, M.; Kamp, C.; Shinaman, A.; Fahn, S. and Lang, A. and the Parkinson's Study Group (2002) JAMA, 287, 1653-1661.
118. Joyce, J.N.; Woolsey, C.; Ryoo, H.; Borwege, S. and Hagner, D. (2004) BMC Biol., 2, 22-33.
119. Colosimo, C. (1999) J. Neurol., 246, 880-882.
120. Ruottinen, H.M. and Rinne, U.K. (1996) J. Neurol. Neurosurg. Psychiatry, 60, 36-40.
121. Parkinson Study Group (1997) Ann. Neurol., 42, 747-755.
122. Factor, S.A. and Weiner, W.J. (2002) Parkinson's Disease. Diagnosis and clinical management. Demos Medical Publishing, New York.
123. Dawson, T.M. and Dawson, V.L. (2002) Nat. Neurosci., 5(Suppl): 1058-1061.
124. Ravina, B.M.; Fagan, S.C.; Hart, R.G.; Hovinga, C.A.; Murphy, D.D., Dawson, T.M. and Marler, J.R. (2003) Neurology, 2003; 60, 1234-1240.
125. Meissner, W.; Hill, M.P.; Tison, F.; Gross, C.E. and Bezard, E. (2004) Trends Pharmacol. Sci., 25, 249-253.
126. Beal, M.F. (2001) Nat. Rev. Neurosci., 2, 326-332.
127. Przedborski, S. and Vila, M. (2003) Ann. N. Y. Acad. Sci., 991, 189-98.
128. Przedborski, S.; Jackson-Lewis, V.; Naini, A.B.; Jakowec, M.; Petzinger, G.; Miller, R. and Akram, M. (2001) J. Neurochem., 76, 1265-1274.
129. Betarbet, R.; Sherer, T.B.; Mackenzie, G.; Garcia-Osuna, M.; Panov, A.V. and Greenamyre, J.T. (2000) Nat. Neurosci., 12, 1301-1306.
130. Fornai, F.; Schluter, O.M.; Lenzi, P.; Gesi, M.; Ruffoli, R.; Ferrucci, M.; Lazzeri, G.; Busceti, C.L.; Pontarelli, F.; Battaglia, G.; Pellegrini, A.; Nicoletti, F.; Ruggieri, S.; Paparelli, A. and Sudhof, T.C. (2005) Proc. Natl. Acad. Sci. USA, 102(9), 3413-8
131. McNaught, K.S.; Perl, D.P.; Brownell, A.L. and Olanow, C.W. (2004) Ann. Neurol., 56(1), 149-62.
132. Masliah, E.; Rockenstein, E.; Veinbergs, I.; Mallory, M.; Hashimoto, M.; Takeda, A.; Sagara, Y.; Sisk, A. and Mucke, L. (2000) Science, 287, 1265-1269.
133. Maries, E.; Dass, B.; Collier, T.J.; Kordower, J.H. and Steece-Collier, K. (2003) Nat. Rev. Neurosci., 4, 727-738.
134. Tomac, A.; Lindqvist, E.; Lin, L.F.H.; Ogren, S.O.; Young, D.; Hoffer, B.J. and Olson, L. (1995) Nature, 373, 335-339.
135. Gash, D.M.; Zhang, Z.; Ovadia, A.; Cass, W.A.; Yi, A.; Simmerman, L.; Russell, D.; Martin, D.; Lapchak, P.A.; Collins, F.; Hoffer, B.J. and Gerhardt, G.A. (1996) Nature, 380, 252-255.
136. Fox, C.M., Gash, D.M., Smoot, M.K. and Cass, W.A. (2001) Brain Res., 896, 56-63.
137. Kordower, J.H.; Emborg, M.E.; Bloch, J.; Ma, S.Y.; Chu, Y.; Leventhal, L.; McBride, J.; Chen, E.Y.; Palfi, S.; Roitberg, B.Z.; Brown, W.D.; Holden, J.E.; Pyzalski, R.; Taylor, M.D.; Carvey, P.; Ling, Z.; Trono, D.; Hantraye, P.; Deglon, N. and Aebischer, P. (2000) Science, 290, 767-773.
138. Gill, S.S.; Patel, N.K.; Hotton, G.R.; O'Sullivan, K.; McCarter, R.; Bunnage, M.; Brooks, D.J.; Svendsen, C.N. and Heywood, P.(2003) Nat. Med., 9, 589-595.
139. Jenner, P. (1998) Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov. Dis., 13, 24-34.
140. Yang, L.; Calingasan, N.Y.; Chen, J.; Ley, J.J.; Becker, D.A. and Beal, M.F. (2005) Exp. Neurol., 191, 86-93.
141. Shults, C.W.; Haas, R.H.; Passov, D. and Beal, M.F. (1997) Ann. Neurol., 42, 261-264.
142. Shults, C.W.; Haas, R.H. and Beal, M.F. (1999) Biofactors, 9, 267-272.
143. Beal, M.F. (1999) Biofactors, 9, 261-266.
144. McGeer, P.L., Itagaki, S., Boyes, B.E. and McGeer, E.G. (1988) Neurology, 38, 1285-1291.
145. Gao, H-G.; Liu, B.; Zhang, W. and Hong, J-S. (2003) Trends Pharmacol. Sci., 24, 395-401.
146. Langston, J.W.; Forno, L.S.; Tetrud, J.; Reeves, A.G.; Kaplan, J.A. and Karluk, D. (1999) Ann. Neurol., 46, 598-605.
147. Kurkowska-Jastrezebska, I.; Wronska, A.; Kohutnicka, M.; Czlonkowski, A. and Czlonkowska, A. (1999) Exp. Neurol., 156, 50-61.
148. Blum, D.; Chtarto, A.; Tenenbaum, L.; Brotchi, J. and Levivier, M. (2004) Neurobiol. Dis., 17, 359-366.
149. Steiner, J.P.; Hamilton, G.S.; Ross, D.T.; Valentine, H.L.; Guo, H.; Connolly, M.A.; Liang, S.; Ramsey, C.; Li, J.H.; Huang, W.; Howorth, P.; Soni, R.; Fuller, M.; Sauer, H.; Nowotnik, A.C. and Suzdak, P.D. (1997) Proc. Natl. Acad. Sci. USA, 94, 2019-2024.
150. Seibyl, J.P.; Marek, K.; Jennings, D.; Powe, L. and Nil-A Trial Group. (2002) Neurology, 58, P03.066.
151. Eberling, J.L.; Pivirotto, P.; Bringas, J.; Steiner, J.P.; Kordower, J.H.; Chu, Y.; Emborg, M.E. and Bankiewicz, K.S. (2002) Exp. Neurol., 178(2), 236-42.
152. Yang, L.; Matthews, R.T.; Schulz, J.B.; Klockgether, T.; Liao, A.W.; Martinou, J.C.; Penney, J.B. Jr; Hyman, B.T. and Beal, M.F. (1998) J. Neurosci., 18, 408-412.
153. Klevenyi, P.; Andreassen, O.; Ferrante, R.J.; Schleicher, J.R. Jr; Friedlander, R.M. and Beal, M.F. (1999) Neuroreport, 10(3), 635-8.
154. Vila, M.; Jackson-Lewis, V.; Vukosavic, S.; Djaldetti, R.; Liberatore, G.; Offen, D.; Korsmeyer, S.J. and Przedborski, S. (2001) Proc. Natl. Acad. Sci. USA, 98, 2837-2842.
155. Trimmer, P.A.; Smith, T. S.; Jung, A.B. and Bennett, J.P. Jr. (1996) Neurodegeneration, 5, 233-239.
156. Eberhardt, O.; Coelln, R.V.; Kugler, S.; Lindenau, J.; Rathke-Hartlieb, S.; Gerhardt, E.; Haid, S.; Isenmann, S.; Gravel, C.; Srinivasan, A.; Bahr, M.; Weller, M.; Dichgans, J. and Schulz, J.B. (2000) J. Neurosci., 20, 9126-9134.
157. Saporito, M.S.; Brown, E.M.; Miller, M.S. and Carswell, S. (1999) J. Pharmacol. Exp. Ther., 288, 421-427.
158. Wang, W.; Ma, C.; Mao, Z. and Li, M. (2004) Drug News Perspect., 17(10), 646-654.
159. Saporito, M.S.; Thomas, B.A. and Scott, R.W. (2000) J. Neurochem., 75, 1200-1208.
160. Ishikawa, A. and Miyatake, T. (1993) J. Neurol. Sci., 117, 28-32.
161. Fagerstrom, K.O.; Pomerleau, O.; Giordani, B. and Stelson, F. (1994) Psychopharmacology, 116, 117-119.
162. Imperato, A.; Mulas, A. and di Chiara, G. (1986) Eur. J. Pharmacol., 132, 337-338.
163. Rapier, C.; Lunt, G.G. and Wonacott, S. (1988) J. Neurochem., 50, 1123-1130.
164. Schneider, J.S.; Pope-Colman, A.; Van Velson, M.; Menzaghi, F. and Lloyd, G.K. (1998) Mov. Dis., 4, 637-642.
165. Baron, J.A. (1996) Br. Med. Bull., 52, 58-73.
166. Balfour, D.J.K. and Fagerstrom, K.O. (1996) Pharmacol. Therapeut., 72, 51-81.
167. O'Neill, M.J.; Murray, T.K.; Lakics, V.; Visanji, N.P. and Duty, S. (2002) Curr. Drug Tragets CNS Neurol. Disord., 1(4), 399-412.
168. Dunnett, S.B.; Björkland, A. and Lindvall, O. (2001) Nat. Rev. Neurosci., 2, 365-369.
169. Freed, C.R.; Greene, P.E.; Breeze, R.E.; Tsai, W.Y.; DuMouchel, W.; Kao, R.; Dillon, S.; Winfield, H.; Culver, S.; Trojanowski, J.Q.; Eidelberg, D. and Fahn, S. (2001) New Eng. J. Med., 344, 710-719.
170. Olanow, C.W.;, Goetz, C.G.; Kordower, J.H.; Stoessl, A.L; Sossi, V.; Brin, M.F.; Shannon, K.M.; Nauert, G.M.; Perl, D.P.; Godbold, J. and Freeman, T.B. (2003) Ann. Neurol., 54(3), 403-14.
171. Chichung Lie, D.; Dziewczapolski, G.; Willhoite, A.R.; Kaspar, B.K.; Shults, C.W. and Gage, F.H. (2002) J. Neurosci., 22, 6639-6649.
172. Kim, J.H.; Auerbach, J.M.; Rodriguez-Gomez, J.A.; Velasco, I.; Gavin, D.; Lumelsky, N.; Lee, S.H.; Nguyen, J.; Sanchez-Pernaute, R.; Bankiewicz, K. and McKay, R. (2002) Nature, 418, 50-56.
173. Nakajima, K.; Hida, H.; Shimano, Y.; Fugimoto, I.; Hashitani, T.; Kumazaki, M.; Sakurai T. and Nishino, H. (2001) Brain Res., 916, 76-84.
174. Rosenbald, C.; Kirik, D. and Bjorklund, A. (2000) Exp. Neurol., 161, 503-516.
175. O'Neill, M.J.; Murray, T.K.; Whalley, K.; Ward, M.A.; Hicks, C.A.; Woodhouse, S.; Osborne, D.J. and Skolnick, P. (2004) Eur. J. Pharmacol., 486(2): 163-174.
176. Benowitz, L.I. and Routtenberg, A. (1997) Trends Neurosci., 20, 84-91.
177. Namgung, U. and Routtenberg, A. (2000) Eur. J. Neurosci., 12, 3124-3136.